Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 468 (ZNF468) is a protein-coding gene that encodes a predicted DNA-binding transcription factor belonging to the C2H2-type zinc finger family, which typically regulates gene expression by sequence-specific binding to DNA. ZNF468 is active in the nucleus and is thought to be involved in RNA polymerase II-dependent transcriptional regulation. It is expressed broadly in tissues with higher levels in placenta, pancreas, and small intestine. Recent research indicates roles in cancer, including promoting malignant growth and chemoresistance in breast cancer cells, and modulating cell cycle and apoptosis in esophageal carcinoma[1][3][7][9][11]. There are currently no known drugs that directly target ZNF468, and it is not considered a standard therapeutic target in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 468 (ZNF468).